PubRank

Adviye Ergul

Author PubWeight™ 83.15‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol 2005 2.88
2 Remote ischemic perconditioning is effective alone and in combination with intravenous tissue-type plasminogen activator in murine model of embolic stroke. Stroke 2012 2.46
3 Targets for vascular protection after acute ischemic stroke. Stroke 2004 1.88
4 Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke. Stroke 2011 1.80
5 Protein nitration impairs the myogenic tone of rat middle cerebral arteries in both ischemic and nonischemic hemispheres after ischemic stroke. Am J Physiol Heart Circ Physiol 2013 1.74
6 Type 2 diabetes causes remodeling of cerebrovasculature via differential regulation of matrix metalloproteinases and collagen synthesis: role of endothelin-1. Diabetes 2005 1.74
7 Blood pressure lowering after experimental cerebral ischemia provides neurovascular protection. J Hypertens 2007 1.71
8 Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study. Stroke 2010 1.69
9 Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke. BMC Neurosci 2006 1.69
10 Adaptive cerebral neovascularization in a model of type 2 diabetes: relevance to focal cerebral ischemia. Diabetes 2009 1.40
11 Minocycline and tissue-type plasminogen activator for stroke: assessment of interaction potential. Stroke 2009 1.30
12 Candesartan augments ischemia-induced proangiogenic state and results in sustained improvement after stroke. Stroke 2009 1.23
13 Hypertension after experimental cerebral ischemia: candesartan provides neurovascular protection. J Hypertens 2006 1.17
14 Cerebral myogenic reactivity and blood flow in type 2 diabetic rats: role of peroxynitrite in hypoxia-mediated loss of myogenic tone. J Pharmacol Exp Ther 2012 1.15
15 Vasoactive factors in sickle cell disease: in vitro evidence for endothelin-1-mediated vasoconstriction. Am J Hematol 2004 1.11
16 Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes. Am J Physiol Regul Integr Comp Physiol 2008 1.11
17 Glycemic control prevents microvascular remodeling and increased tone in type 2 diabetes: link to endothelin-1. Am J Physiol Regul Integr Comp Physiol 2009 1.11
18 Effect of neutrophil depletion on gelatinase expression, edema formation and hemorrhagic transformation after focal ischemic stroke. BMC Neurosci 2005 1.11
19 Vascular protection in diabetic stroke: role of matrix metalloprotease-dependent vascular remodeling. J Cereb Blood Flow Metab 2010 1.10
20 Vascular protection by angiotensin receptor antagonism involves differential VEGF expression in both hemispheres after experimental stroke. PLoS One 2011 1.10
21 Neurovascular injury in acute hyperglycemia and diabetes: A comparative analysis in experimental stroke. Transl Stroke Res 2011 1.08
22 Targets of vascular protection in acute ischemic stroke differ in type 2 diabetes. Am J Physiol Heart Circ Physiol 2013 1.07
23 Sex-independent neuroprotection with minocycline after experimental thromboembolic stroke. Exp Transl Stroke Med 2011 1.07
24 AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator. J Pharmacol Exp Ther 2012 1.07
25 Vascularization pattern after ischemic stroke is different in control versus diabetic rats: relevance to stroke recovery. Stroke 2013 1.05
26 Evidence for a matrix metalloproteinase induction/activation system in arterial vasculature and decreased synthesis and activity in diabetes. Diabetes 2002 1.05
27 Differential effects of ET(A) and ET(B) receptor antagonism on oxidative stress in type 2 diabetes. Vascul Pharmacol 2007 1.04
28 Enhanced cerebral but not peripheral angiogenesis in the Goto-Kakizaki model of type 2 diabetes involves VEGF and peroxynitrite signaling. Diabetes 2012 1.02
29 Type-2 diabetes-induced changes in vascular extracellular matrix gene expression: relation to vessel size. Cardiovasc Diabetol 2006 1.02
30 Tactics for vascular protection after acute ischemic stroke. Pharmacotherapy 2005 1.01
31 Diet-induced obesity causes cerebral vessel remodeling and increases the damage caused by ischemic stroke. Microvasc Res 2009 1.00
32 Early atorvastatin reduces hemorrhage after acute cerebral ischemia in diabetic rats. J Pharmacol Exp Ther 2009 0.99
33 Oxidative stress and cardiovascular disease: antioxidants and unresolved issues. Cardiovasc Drug Rev 2005 0.99
34 Cerebral neovascularization and remodeling patterns in two different models of type 2 diabetes. PLoS One 2013 0.98
35 Thioredoxin-interacting protein is required for endothelial NLRP3 inflammasome activation and cell death in a rat model of high-fat diet. Diabetologia 2013 0.98
36 Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes. Am J Physiol Regul Integr Comp Physiol 2005 0.97
37 O-GlcNAcylation contributes to augmented vascular reactivity induced by endothelin 1. Hypertension 2009 0.96
38 Early effects of high-fat diet on neurovascular function and focal ischemic brain injury. Am J Physiol Regul Integr Comp Physiol 2013 0.95
39 Evidence for vasculoprotective effects of ETB receptors in resistance artery remodeling in diabetes. Diabetes 2007 0.95
40 Effect of chronic and selective endothelin receptor antagonism on microvascular function in type 2 diabetes. Am J Physiol Heart Circ Physiol 2008 0.95
41 Endothelial endothelin B receptor-mediated prevention of cerebrovascular remodeling is attenuated in diabetes because of up-regulation of smooth muscle endothelin receptors. J Pharmacol Exp Ther 2010 0.94
42 Remote ischemic perconditioning is effective after embolic stroke in ovariectomized female mice. Transl Stroke Res 2014 0.94
43 Microvascular versus macrovascular dysfunction in type 2 diabetes: differences in contractile responses to endothelin-1. Exp Biol Med (Maywood) 2006 0.92
44 Impaired insulin-mediated vasorelaxation in a nonobese model of type 2 diabetes: role of endothelin-1. Can J Physiol Pharmacol 2008 0.92
45 Comparative analysis of the neurovascular injury and functional outcomes in experimental stroke models in diabetic Goto-Kakizaki rats. Brain Res 2013 0.91
46 Remote ischemic postconditioning: harnessing endogenous protection in a murine model of vascular cognitive impairment. Transl Stroke Res 2014 0.91
47 Native matrix metalloproteinase characteristics may influence early stenosis of venous versus arterial coronary artery bypass grafting conduits. Chest 2004 0.90
48 Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension. J Sex Med 2008 0.90
49 Candesartan induces a prolonged proangiogenic effect and augments endothelium-mediated neuroprotection after oxygen and glucose deprivation: role of vascular endothelial growth factors A and B. J Pharmacol Exp Ther 2014 0.90
50 Effects of spironolactone on cerebral vessel structure in rats with sustained hypertension. Am J Hypertens 2011 0.89
51 Nox2-derived superoxide contributes to cerebral vascular dysfunction in diet-induced obesity. Stroke 2013 0.88
52 Erectile dysfunction in young non-obese type II diabetic Goto-Kakizaki rats is associated with decreased eNOS phosphorylation at Ser1177. J Sex Med 2010 0.88
53 Nuclear localization of endothelin-converting enzyme-1: subisoform specificity. Arterioscler Thromb Vasc Biol 2003 0.88
54 Comparison of selective versus dual endothelin receptor antagonism on cerebrovascular dysfunction in diabetes. Neurol Res 2011 0.87
55 Differential effects of diet-induced dyslipidemia and hyperglycemia on mesenteric resistance artery structure and function in type 2 diabetes. J Pharmacol Exp Ther 2008 0.86
56 Thioredoxin-interacting protein: a novel target for neuroprotection in experimental thromboembolic stroke in mice. Mol Neurobiol 2014 0.85
57 DOCA-salt treatment enhances responses to endothelin-1 in murine corpus cavernosum. Can J Physiol Pharmacol 2008 0.85
58 Saphenous vein endothelin system expression and activity in African American patients. Arterioscler Thromb Vasc Biol 2002 0.85
59 Interleukin-10 attenuates vascular responses to endothelin-1 via effects on ERK1/2-dependent pathway. Am J Physiol Heart Circ Physiol 2008 0.84
60 Low-dose candesartan enhances molecular mediators of neuroplasticity and subsequent functional recovery after ischemic stroke in rats. Mol Neurobiol 2014 0.84
61 Reduced endothelium-dependent relaxation to anandamide in mesenteric arteries from young obese Zucker rats. PLoS One 2013 0.84
62 The effect of endothelin receptor A antagonism on basilar artery endothelium-dependent relaxation after ischemic stroke. Life Sci 2012 0.84
63 Phosphorylation of endothelin converting enzyme-1 isoforms: relevance to subcellular localization. Exp Biol Med (Maywood) 2006 0.83
64 Dual endothelin receptor antagonism prevents remodeling of resistance arteries in diabetes. Can J Physiol Pharmacol 2010 0.83
65 Endothelin-1-mediated cerebrovascular remodeling is not associated with increased ischemic brain injury in diabetes. Can J Physiol Pharmacol 2010 0.82
66 Sepiapterin decreases vasorelaxation in nitric oxide synthase inhibition-induced hypertension. J Cardiovasc Pharmacol 2004 0.82
67 Candesartan reduces the hemorrhage associated with delayed tissue plasminogen activator treatment in rat embolic stroke. Neurochem Res 2013 0.82
68 Comparative Analysis of Different Methods of Ischemia/Reperfusion in Hyperglycemic Stroke Outcomes: Interaction with tPA. Transl Stroke Res 2015 0.81
69 Recommendations for preclinical research in hemorrhagic transformation. Transl Stroke Res 2013 0.81
70 Internal pudendal artery from type 2 diabetic female rats demonstrate elevated endothelin-1-mediated constriction. J Sex Med 2011 0.81
71 Peroxynitrite mediates testosterone-induced vasodilation of microvascular resistance vessels. J Pharmacol Exp Ther 2013 0.79
72 Neuroprotection by tempol in a model of iron-induced oxidative stress in acute ischemic stroke. Am J Physiol Regul Integr Comp Physiol 2003 0.79
73 Minocycline prevents IL-6 increase after acute ischemic stroke. Transl Stroke Res 2012 0.79
74 Lacidipine has antiatherosclerotic effects independent of its actions on lipid metabolism and blood pressure. Vascul Pharmacol 2010 0.77
75 Vascular endothelin converting enzyme-1 expression and activity is upregulated in clinical diabetes. Ethn Dis 2002 0.77
76 Augmented dilation to nitric oxide in uterine arteries from rats with type 2 diabetes: implications for vascular adaptations to pregnancy. Am J Physiol Heart Circ Physiol 2013 0.76
77 Oxidative stress and cardiovascular risk in overweight children in an exercise intervention program. Child Obes 2012 0.76
78 Response to letter regarding article, "Remote ischemic perconditioning is effective alone and in combination with intravenous tissue-type". Stroke 2013 0.75
79 Selective downregulation of endothelin-B receptors in diabetic African-American patients. Ethn Dis 2002 0.75
80 Decreased vascular matrix metalloproteinase abundance in diabetic patients with symptomatic macroangiopathy. Ethn Dis 2002 0.75
81 Erratum to: Thioredoxin-interacting protein: a novel target for neuroprotection in experimental thromboembolic stroke in mice. Mol Neurobiol 2015 0.75